- Home
- SNOA vs KTTA Comparison
SNOA vs KTTA Comparison
Compare SNOA & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOA
- KTTA
- Stock Information
- Founded
- SNOA 1999
- KTTA 2020
- Country
- SNOA United States
- KTTA United States
- Employees
- SNOA N/A
- KTTA N/A
- Industry
- SNOA Biotechnology: Pharmaceutical Preparations
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- SNOA Health Care
- KTTA Health Care
- Exchange
- SNOA Nasdaq
- KTTA Nasdaq
- Market Cap
- SNOA 6.9M
- KTTA 5.7M
- IPO Year
- SNOA 2007
- KTTA 2021
- Fundamental
- Price
- SNOA $4.00
- KTTA $0.72
- Analyst Decision
- SNOA
- KTTA
- Analyst Count
- SNOA 0
- KTTA 0
- Target Price
- SNOA N/A
- KTTA N/A
- AVG Volume (30 Days)
- SNOA 76.8K
- KTTA 79.1K
- Earning Date
- SNOA 11-07-2025
- KTTA 11-14-2025
- Dividend Yield
- SNOA N/A
- KTTA N/A
- EPS Growth
- SNOA N/A
- KTTA N/A
- EPS
- SNOA N/A
- KTTA N/A
- Revenue
- SNOA $14,912,000.00
- KTTA N/A
- Revenue This Year
- SNOA $23.00
- KTTA N/A
- Revenue Next Year
- SNOA $24.59
- KTTA N/A
- P/E Ratio
- SNOA N/A
- KTTA N/A
- Revenue Growth
- SNOA 17.43
- KTTA N/A
- 52 Week Low
- SNOA $1.75
- KTTA $0.65
- 52 Week High
- SNOA $6.92
- KTTA $4.35
- Technical
- Relative Strength Index (RSI)
- SNOA 49.74
- KTTA 46.19
- Support Level
- SNOA $3.57
- KTTA $0.69
- Resistance Level
- SNOA $4.02
- KTTA $0.78
- Average True Range (ATR)
- SNOA 0.23
- KTTA 0.04
- MACD
- SNOA 0.00
- KTTA -0.00
- Stochastic Oscillator
- SNOA 58.63
- KTTA 33.17
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).